The NHS Sussex integrated care board has been escalated to 'tier 2' oversight following a review that uncovered significant failings in its leadership and culture, raising serious concerns for health services across Brighton and East Sussex.
A British mother who lost eight stone using 'fat jabs' has sparked a fierce debate by arguing the NHS should not fund them for weight loss, calling it a personal lifestyle choice rather than an essential right.
UK health officials issue urgent safety alert for popular slimming injections like Ozempic and Wegovy. Patients must disclose use before operations to prevent dangerous complications.
Shadow Health Secretary Wes Streeting delivers a blistering assessment of the NHS, branding it 'broken' and vowing a fundamental transformation to prioritise patient care and efficiency if Labour wins the next election.
Groundbreaking research from Tufts University reveals that drugs like Ozempic and Wegovy are dramatically more effective for weight loss than traditional diet and exercise alone, potentially transforming the NHS's approach to the obesity epidemic.
A UK mother's revelation that she uses her disability benefits to pay for weight-loss jabs like Wegovy has ignited a fierce national debate on welfare spending, medical ethics, and obesity treatment.
Exclusive: The UK government faces imminent NHS strike escalation as unions vow to combat plans replacing striking staff with outsourced workers, potentially prolonging the largest walkout in health service history.
The World Health Organisation makes a landmark decision, adding weight-loss injections like Wegovy to its Essential Medicines List, signalling a new front in the global fight against obesity.
The NHS in England is set to provide the highly effective Mounjaro (tirzepatide) weight-loss injection, hailed as a major breakthrough in fighting obesity and related diseases like type 2 diabetes.
The NHS is dramatically expanding the availability of prescription weight-loss injections, hailed as a 'game-changer' in treating obesity. This major rollout could benefit hundreds of thousands more patients across England.
Shadow Health Secretary Wes Streeting delivers a stark diagnosis of the NHS, labelling it 'broken' and vowing a fundamental transformation to save the cherished institution from collapse.
Health experts sound the alarm on a worrying new trend where individuals are microdosing powerful diabetes and weight-loss medications like Ozempic to shed pounds, despite severe health risks and a complete lack of evidence for its safety or efficacy.
UK researchers are exploring a revolutionary 'microdosing' strategy for powerful weight-loss medications like Wegovy, potentially slashing costs and side effects while boosting accessibility for NHS patients.
Exclusive investigation reveals the staggering postcode lottery and soaring costs of life-changing obesity drugs like Mounjaro and Wegovy, as the NHS struggles to cope with unprecedented demand.
Former Culture Minister Ed Vaizey calls for VAT removal on prescription obesity drugs, arguing it would boost public health and reduce long-term NHS costs.
Ex-Culture Minister Ed Vaizey urges the NHS to widely prescribe revolutionary weight loss injections, calling them a potential 'miracle' for public health and a solution to the obesity crisis.
Exclusive: Medical experts warn of a deepening postcode lottery and a surge in the illegal black market for weight-loss jabs as NHS England struggles with supply and soaring demand for GLP-1 drugs.
Eli Lilly drastically cuts the price of its Mounjaro injection in the UK, making the revolutionary diabetes and weight loss treatment more accessible. The move follows a landmark NHS supply deal.
The UK's medicines watchdog approves the weight loss injection Mounjaro (tirzepatide), offering a powerful new option in the fight against obesity. Discover its price, how it works, and where to get it.
NHS England deploys a unique team of 'people experts' to hospitals in South London to manage severe winter pressures, patient flow, and staff welfare during a major incident.
Exclusive analysis reveals a dramatic surge in Britons turning to private medical care, driven by unprecedented NHS waiting times and a perceived 'postcode lottery' for treatment. This investigation uncovers the human cost of the healthcare crisis.
Exclusive NHS data reveals a shocking rise in children as young as ten being prescribed anti-obesity injections like Wegovy, raising serious safety concerns among medical experts.
Exclusive investigation reveals NHS splurged millions on PR and communications staff while GP practices struggle with funding shortages and patient backlogs.
The soaring cost of revolutionary new obesity drugs like Wegovy could force the NHS into a stark choice: ration treatments or find billions in new funding. This investigation reveals the immense financial pressure facing the health service.
Tennis legend Serena Williams and Reddit co-founder Alexis Ohanian endorse GLP-1 medications, advocating for their benefits while calling for reduced stigma and improved accessibility in weight management treatment.
A British woman's life-changing weight loss journey using Mounjaro injections has been thrown into turmoil after a dramatic price increase made the drug unaffordable, forcing her to confront the return of debilitating 'food noise'.
Scotland's NHS is spending a staggering £10 million annually on weight-loss injections like Ozempic and Wegovy as the nation battles a severe obesity epidemic. This investigative report reveals the soaring prescription costs and the pressing health challe
A potential second Trump presidency could trigger massive price hikes for life-changing diabetes and obesity medications due to proposed import tariffs, putting essential treatments at risk for millions of Britons.
Exclusive: A dramatic price war has broken out for 'game-changer' weight loss drugs Wegovy and Mounjaro in the UK, making them more accessible through private providers but raising concerns for the NHS.
Groundbreaking research suggests popular weight loss injections like Wegovy and Ozempic could significantly lower the risk of obesity-related cancers, offering a potential double benefit for millions.